Conservation of Mannan Synthesis in Fungi of the Zygomycota and Ascomycota Reveals a Broad Diagnostic Target
- PMID: 29720523
- PMCID: PMC5932377
- DOI: 10.1128/mSphere.00094-18
Conservation of Mannan Synthesis in Fungi of the Zygomycota and Ascomycota Reveals a Broad Diagnostic Target
Abstract
Ascomycetes and zygomycetes account for the majority of (i) fungi responsible for cutaneous, subcutaneous, and invasive human fungal infections, (ii) plant fungal pathogens, (iii) fungi that threaten global biodiversity, (iv) fungal agents of agricultural spoilage, and (v) fungi in water-damaged buildings. Rapid recognition of fungal infection (or contamination) enables early treatment (or remediation). A bioinformatics search found homologues of Saccharomyces cerevisiae Mnn9p present in members of the Zygomycota and Ascomycota phyla and absent in members of the Chytridiomycota and Basidiomycota. Mnn9p is a component of the yeast mannan polymerization complex and is necessary for α-1,6 mannan production. A monoclonal antibody (2DA6) was produced that was reactive with purified mannans of Mucor, Rhizopus, Aspergillus, Fusarium, and Candida species. Experimentation using a 2DA6 antigen capture enzyme-linked immunosorbent assay (ELISA) and extracts of fungi from the four phyla found agreement between the presence or absence of Mnn9p homologues and production or lack of production of mannan reactive with 2DA6. Studies of cell extracts from yeast mannan mutants identified α-1,6 mannan as the epitope recognized by 2DA6. To translate this finding into a point-of-use diagnostic, a 2DA6 lateral flow immunoassay was constructed that detected mannan in (i) extracts of dermatophytes and fungi that produce trauma-related infection and (ii) tissue from plants infected with Grosmannia clavigera or Sclerotium cepivorum These studies (i) revealed that the conservation of α-1,6-linked mannan in fungi of the Zygomycota and Ascomycota can be exploited as a broad diagnostic target and (ii) have provided a means to detect that target in an immunoassay platform that is well suited for clinic or field use.IMPORTANCE A key question asked when faced with an infection, an infestation, or environmental damage is whether it is a fungus. Identification of fungi as the cause of the problem can lead to remediation or treatment. Zygomycetes and ascomycetes account for the vast majority of fungal causes of human, animal, and plant disease, large-scale biodiversity loss, agricultural spoilage, and contamination of water-damaged buildings. These studies revealed the conservation of a common cell wall structural component of zygomycetes and ascomycetes to be a diagnostic target applicable to multiple pathogenic fungi and have leveraged that insight for practical use. Monoclonal antibodies reactive with this pan-fungal structure were produced and used to construct immunoassays (including ELISA and lateral flow assay) for detection of a broad range of pathogenic fungi.
Keywords: Mnn9; diagnostics; immunodetection; invasive fungal infection; lateral flow immunoassay; mannan; point of care.
Copyright © 2018 Burnham-Marusich et al.
Figures
Similar articles
-
[Demonstration of β-1,2 mannan structures expressed on the cell wall of Candida albicans yeast form but not on the hyphal form by using monoclonal antibodies].Mikrobiyol Bul. 2015 Jan;49(1):66-76. doi: 10.5578/mb.8640. Mikrobiyol Bul. 2015. PMID: 25706732 Turkish.
-
Well-characterized monoclonal antibodies against cell wall antigen of Aspergillus species improve immunoassay specificity and sensitivity.Clin Vaccine Immunol. 2008 Feb;15(2):194-202. doi: 10.1128/CVI.00362-07. Epub 2007 Nov 21. Clin Vaccine Immunol. 2008. PMID: 18032591 Free PMC article.
-
Loss of the flagellum happened only once in the fungal lineage: phylogenetic structure of kingdom Fungi inferred from RNA polymerase II subunit genes.BMC Evol Biol. 2006 Sep 29;6:74. doi: 10.1186/1471-2148-6-74. BMC Evol Biol. 2006. PMID: 17010206 Free PMC article.
-
[Serologic diagnosis of fungal infections].Nihon Rinsho. 2008 Dec;66(12):2313-8. Nihon Rinsho. 2008. PMID: 19069098 Review. Japanese.
-
The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia.Crit Care. 2010;14(6):R222. doi: 10.1186/cc9365. Epub 2010 Dec 8. Crit Care. 2010. PMID: 21143834 Free PMC article. Review.
Cited by
-
From Spores to Solutions: A Comprehensive Narrative Review on Mucormycosis.Diagnostics (Basel). 2024 Jan 31;14(3):314. doi: 10.3390/diagnostics14030314. Diagnostics (Basel). 2024. PMID: 38337830 Free PMC article. Review.
-
Severe Fatal Mucormycosis in a Patient with Chronic Lymphocytic Leukaemia Treated with Zanubrutinib: A Case Report and Review of the Literature.Curr Oncol. 2023 Sep 7;30(9):8255-8265. doi: 10.3390/curroncol30090599. Curr Oncol. 2023. PMID: 37754514 Free PMC article.
-
Epidemiology, Modern Diagnostics, and the Management of Mucorales Infections.J Fungi (Basel). 2023 Jun 12;9(6):659. doi: 10.3390/jof9060659. J Fungi (Basel). 2023. PMID: 37367595 Free PMC article. Review.
-
Novel Approaches in the Management of Mucormycosis.Curr Fungal Infect Rep. 2023 May 8:1-10. doi: 10.1007/s12281-023-00463-3. Online ahead of print. Curr Fungal Infect Rep. 2023. PMID: 37360854 Free PMC article. Review.
-
Innate Immune Memory in Macrophages.Newborn (Clarksville). 2023 Jan-Mar;2(1):60-79. doi: 10.5005/jp-journals-11002-0058. Epub 2023 Apr 6. Newborn (Clarksville). 2023. PMID: 37206580 Free PMC article.
References
-
- Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, et al. . 2012. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2163–2196. doi:10.1016/S0140-6736(12)61729-2. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
